PDL BioPharma (PDLI)
PDL BioPharma Cash Flow
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Cash Flow - Operations | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Income | 40.18M | 38.94M | 45.92M | 69.99M | 44.54M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation, Depletion, Amortization | 3.966M | 2.95M | 3.629M | 2.388M | 2.357M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Non-Cash Items | 2.249M | 6.231M | 5.823M | 20.14M | 0.052M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Non-Cash Items | 6.215M | 9.181M | 9.452M | 22.53M | 2.409M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Income Taxes | -12.58M | 12.58M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||
| Total Changes in Assets/Liabilities | -28.50M | -2.977M | -18.66M | 8.557M | -60.11M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Operating Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Operating Activities | 17.90M | 45.15M | 36.71M | 101.08M | -13.15M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Investing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Capital Expenditures | -0.008M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||||
| Acquisitions, Divestitures | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Investments | 8.007M | 8.503M | -0.338M | -1.781M | -30.43M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Investing Activities | -7.425M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||||
| Cash Flow - Financing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Cash from Investing Activities | 0.574M | 8.503M | -0.288M | -1.831M | -30.43M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Debt Issued | -23.84M | -21.28M | -26.36M | -27.08M | -20.31M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Equity Issued | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Dividends Paid | -20.96M | -20.95M | -20.95M | -20.96M | -20.97M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Financing Activities | -0.845M | 0.00 | 0.00 | -9.897M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Net Cash from Financing Activities | -45.65M | -42.24M | -47.32M | -57.94M | -41.28M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Foreign Exchange Effects | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Change in Cash & Cash Equivalents | -27.18M | 11.41M | -10.89M | 41.31M | -84.86M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at beginning of period | 168.54M | 211.57M | 168.54M | 157.13M | 168.02M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at end of period | 141.37M | 168.54M | 157.13M | 168.02M | 126.71M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
